Anzeige
Mehr »
Login
Freitag, 27.09.2024 Börsentäglich über 12.000 News von 690 internationalen Medien
Insider-Alarm: Warum Insider Millionen von Aktien dieses Goldwerts kaufen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
500 Leser
Artikel bewerten:
(2)

Catella - Property Investment Management: EXTENDAM, CEDRE and CATELLA HOSPITALITY EUROPE acquire the iconic Hotel La Pérouse in Nice

STOCKHOLM, Nov. 18, 2021 /PRNewswire/ -- A joint-venture led by Catella Hospitality Europe (CHE), Extendam and Cèdre has acquired the Hotel La Pérouse, a legendary boutique-hotel in Nice overlooking the famous "Baie des Anges". This new acquisition is motivated by the unique features of the hotel as well as the demonstrated dynamism of Nice to be further consolidated with its recent UNESCO heritage site award.

Nestled on the "Colline du Château", at immediate vicinity from the old town of Nice, the Hotel La Pérouse offers a high-end experience to guests thanks to its exclusive environment and tailored services. Located on the famous "Promenade des Anglais", the hotel features 56 rooms and suites, most of which with private terraces or balconies offering bird's-eye views over the Mediterranean Sea.

Nice - "the winter resort town of the French Riviera" - constantly ranks among the most visited cities in France and earned in May 2021 the UNESCO world heritage status which will further boost visitation in the coming years. Tourism is deeply rooted in the city's DNA, which offers landmarks such as the Promenade des Anglais, Matisse and Chagall Museums, the Castle of Nice, the flower market, etc. A highly leisure-driven hotel market, Nice is poised for quick recovery post-pandemic. The summer period this year already marked a real boost in terms of hotel demand, with the overall Côte-d'Azur hotel market achieving a performance above that of 2019.

Catella Hospitality Europe, Extendam and Cèdre intend to reposition the Hotel La Pérouse as Nice's best luxury boutique hotel. In partnership with an internationally-renown designer, the new owners will fully renovate the property and enhance all common areas, to fully capitalize on the asset's unique specificities and authenticity. A key element of the renovation program will be to create new attractive food and beverage outlets, appealing to the local community and visitors alike.

Buy-side counsels working on the transaction were Arago, Chevreux (notary), Hoche Avocats, NS Associés, Capstan, and Delpha Conseil.

The managing partners, at CATELLA HOSPITALITY EUROPE, said:

"We are highly delighted to invest once more in Nice, and to take-over such high-potential property which sits in a unique location. The team aims at fully renovating this "sleeping beauty" - further contributing to the upscaling of Nice's hotel market".

Jean-Marc Palhon, Chairman of EXTENDAM, said:

"Nice is an attractive city we know well for having acquired several establishments there. La Pérouse hotel performed well in 2019, before the health crisis. The work we are undertaking to upgrade the hotel will place it as the only boutique-hotel of such standing in Nice and will give it every chance of even better results. We also have complete confidence in the teams of Catella Hospitality Europe to design a bright future for this new asset. This off-market operation is fully in line with EXTENDAM's value-add investment strategy".

About EXTENDAM

EXTENDAM is a French independent asset management company dedicated to private and institutional investors, regulated by the AMF (the French financial markets authority). Since inception, our funds have invested in more than 250 hotels across EMEA, representing a combined asset value in excess of €2.4 billion. We partner with global operators and franchisors, white label management companies as well as local hoteliers in order to create value for our investors through active asset management. For more information: www.extendam.com. Follow us on LinkedIn an Twitter: EXTENDAM et @EXTEND_AM

About CÈDRE

Cèdre is a family-owned investment holding company, targeting French companies with strong growth potential. For more than 20 years, Cèdre has supported the development of meaningful projects by investing in promising companies. Cèdre invests tickets from €2 million to €15 million, either alone or in co-investment, without time constraints. Cèdre owns several hotels in Paris and on the Mediterranean coast. For more information: www.cedre-pe.com

About CATELLA HOSPITALITY EUROPE

Catella Hospitality Europe (CHE) invests and assists investors from the sourcing, structuring, and managing of tailored hotel investment opportunities, assessing, and executing each opportunity in order to create the optimum Risk/Reward. Based in Paris, the team has structured deals and managed properties in France and across other main European countries (the United Kingdom, Germany, Spain, Belgium, Poland etc.). CHE was launched in June 2019.

For more information: www.catella.com

For further information, please contact:

CATELLA HOSPITALITY EUROPE
Pierre-Louis BELLANGER
pilou@che-im.com

Maxime DES MONSTIERS
maxime@che-im.com

Rodolphe FRÉGÉ
rodolphe@che-im.com

Press Contacts:
CATELLA FRANCE
Oceane VINSON
Head of Marketing & Communication
+33 1 56 79 79 78
Oceane.Vinson@catella.fr

EXTENDAM
Annabelle LEDOUX
+33 6 10 79 07 65
aled@lesgrandesidees.fr

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/catella---property-investment-management/r/extendam--cedre-and-catella-hospitality-europe-acquire-the-iconic-hotel-la-perouse-in-nice,c3455597

© 2021 PR Newswire
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.